School Of Medicine Basic Sciences

Tina Iverson, Louise B. McGavock Chair and Professor of pharmacology and biochemistry, will take the role of associate dean for faculty on July 1, 2024. Read More

By targeting a notoriously undruggable protein found in many cancers, the discovery of BI-0474 may pave the way for new cancer treatments. Shared on opnMe.com by Boehringer Ingelheim, this innovative molecule is available for global researchers to explore new research avenues. Read More

Foundational research from the Hiebert lab reveals genetic targets that can be leveraged to identify therapies that affect lymphoma cell growth. Read More

New work by Professor of Cell and Developmental Biology Bill Tansey and colleagues has determined that a new type of inhibitor—a WINi—targets cancer cells in a novel way and suggests exploiting this pathway in future anticancer drug development efforts. Read More

Meet Stephen Doster, ‪associate program director of academic and educational support‬ in Basic Sciences. Read More

Seminar series by biomedical scientists from across the nation brings research collaboration opportunities to trainees and students from Nashville universities. Read More

The Cell Imaging Shared Resource launches an image contest to highlight the stunning scientific images captured with CISR instruments. Cash prizes will be awarded to winning submissions. Read More

Benjamin P. Brown, assistant professor of pharmacology, and colleagues in the departments of molecular physiology and biophysics, pharmacology, and chemistry, have determined that AlphaFold2 can be used to generate approximations of relative conformational preferences of proteins, which will help researchers better understand a protein’s structure and function across a range of conditions and mutational states. Read More

Vanderbilt’s cell and developmental biology department is the third-most NIH-funded in the nation. Biochemistry, pharmacology, and molecular physiology and biophysics are in the top 15. Read More

While at Vanderbilt, Williams will work with Hinton to identify novel treatment targets for chronic kidney disease, a disease most caused by hypertension and diabetes. Williams will continue to actively engage in outreach activities, professional service, and research endeavors to uplift underrepresented minority students in the scientific community. Read More